Reagent kit for detection of SARS-CoV-2 coronavirus RNA by real-time RT-PCR. Does not contain reagents for isolation of NK.
– The kit is available as a ready-made lyophilizing mixture for RT-PCR.
– Does not require a separate reversal procedure
– Designed for use with CFX96 recording amplifiers (Bio-Rad, USA); DTprime (NPO DNA-Technology LLC, Russia)
Storage of the kit components is carried out at a temperature of 2-8 ℃; transportation at temperatures up to 26 ℃ for no more than 10 days is allowed.
The set is designed for 96 definitions.
RealBest Sorbitus (option 4×24)
A set of reagents for the isolation of nucleic acids from clinical samples. In the variant 4×24 and 1×96.
Designed for 96 definitions.
Transport solution (M)
Reagent for taking, transporting and storing clinical material (smears from the nose, nasopharynx, oropharynx, sputum). Buffer solution based on 5 M guanidine in 100 test tubes 13×75 mm with screw caps, 2 ml each
SARS-CoV-2-IgG spectrum-EIA-BEST
Enzyme immunoassay kit for the differential detection of IgG to S- and N-proteins of SARS-CoV-2.
– Samples are serum and plasma
– Kits contain reagents for 96 tests including control samples. Split usage is possible
– Ready-to-use components
– Storage temperatureis 2-8 C
– Total reaction time is 85 min
– Transportation at the temperature up to 26 C for 10 days is acceptable
SARS-CoV-2-IgG quantitive-EIA-BEST
Enzyme immunoassay kit for the quantification of IgG to SARS-CoV-2.
4 calibration samples validated against First WHO International Standartd for anti-SARS-CoV-2 immunoglobulin (human), NIBSC code: 20/136
Linear range
– Measurement at 450 nm
10-125 BAU/ml
– Measurement at 405 nm
10-500 BAU/ml
SARS-CoV-2-AB-EIA-BEST
Enzyme immunoassay kit for the detection of total antibodies to SARS-CoV-2. IgA, IgM, IgG
SARS-CoV-2-IgA-ELISA-BEST
Enzyme immunoassay kit for the detection of IgA to SARS-CoV-2
SARS-CoV-2-IgМ-EIA-BEST
Enzyme immunoassay kit for the detection of IgM to SARS-CoV-2
SARS-CoV-2-IgG-EIA-BEST
Enzyme immunoassay kit for the detection of IgG to SARS-CoV-2